Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.830
+0.410 (16.94%)
At close: Jun 6, 2025, 4:00 PM
2.840
+0.010 (0.35%)
After-hours: Jun 6, 2025, 7:59 PM EDT
Adverum Biotechnologies Employees
Adverum Biotechnologies had 155 employees as of December 31, 2024. The number of employees increased by 34 or 28.10% compared to the previous year.
Employees
155
Change (1Y)
34
Growth (1Y)
28.10%
Revenue / Employee
$6,452
Profits / Employee
-$972,897
Market Cap
59.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ADVM News
- 1 day ago - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights - GlobeNewsWire
- 5 weeks ago - Adverum Biotechnologies, Inc. (ADVM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 5 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Adverum Biotechnologies, Inc. (ADVM) Shareholders to Inquire about Securities Investigation - Accesswire
- 5 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Adverum Biotechnologies, Inc. (ADVM) And Encourages Shareholders to Connect - Accesswire
- 6 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Adverum Biotechnologies, Inc. (ADVM) Stockholders to Inquire about Securities Investigation - Accesswire
- 6 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Adverum Biotechnologies, Inc. (ADVM) and Encourages Investors to Learn More About the Investigation - Accesswire
- 6 weeks ago - Adverum Biotechnologies, Inc. (ADVM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire